JANX
Janux Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.24
+2.22%Aug 6, 2026, 22:21 UTC
Janux Therapeutics reported a second-quarter net loss of $0.35 per share, missing the Zacks Consensus Estimate of a $0.26 loss, and compared to a $0.55 loss per share in the same quarter last year.
Source: